## Abstract Expression of MAGE genes that encode tumor‐rejection antigens recognized by cytotoxic T lymphocytes with major histocompatibility complex class‐I antigens was investigated in human osteosarcomas (20 cell lines and eight fresh tumor tissues). MAGE‐1,2,3,4, and 6 genes were expressed at t
Expression of major vault protein gene in osteosarcoma patients
✍ Scribed by Cristiane Arruda Dalla-Torre; Silvia Regina Caminada de Toledo; Maisa Yoshimoto; Antônio Sérgio Petrilli; Joyce Anderson Duffles Andrade; Susan Chilton-MacNeill; Jeremy A. Squire; Maria Zielenska
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 120 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Osteosarcoma (OS) is a primary malignant tumor of bone. Despite the successful use of multiple chemotherapeutic agents in the treatment of OS, more than 30% of OS tumors remain resistant to treatment. Elucidation of cellular resistance mechanisms may lead to better treatments for cancer patients. In this study, we used the low‐density expression cDNA array, GEArray Q Series Human Cancer Drug Resistance and Metabolism Gene Array to screen genes related to drug resistance in 15 OS tumors. Expression patterns of the MPV gene were validated by real time PCR on 45 OS patient tumor samples and correlated with clinical and pathological data. Major vault protein (MVP) expression was present in 24 (53%) tumor samples and absent in 21 (47%). Samples from surgery showed correlation between the expression of MVP, metastatic disease at diagnosis and event free survival (EFS). The MVP gene expression correlates with metastatic disease at diagnosis after neoadjuvant chemotherapy (p = 0.048), and is also associated with worse EFS (p = 0.036). These findings suggest that MVP expression is involved in one of the mechanisms of drug resistance in OS and is induced by chemotherapy. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:958–963, 2007
📜 SIMILAR VOLUMES
## Dear Sir, Osteosarcoma is the most frequent primary malignant bone tumor, excluding plasma cell myeloma. Although multimodal treatment includes wide local excision and adjuvant chemo-
Demyelinating diseases, such as multiple sclerosis (MS) in man or experimental allergic encephalomyelitis (EAE) in rodents, may include an associated immune response directed against myelin protein antigens such as the proteolipid protein (PLP) and the myelin basic protein (MBP). Development of an i
Evidence has shown that the major human vault protein (MVP), which is identical to lung resistance-related protein (LRP), may be causally involved in a special type of multidrug resistance (MDR). The purpose of this study was to investigate the expression and cellular localization of MVP in cells de
Gene expression of major urinary protein (MUP) mRNAs was examined in the mouse nasal tissue. By polymerase chain reaction, we identified two cDNA segments encoding MUP 4 and MUP 5 genes in the nose. The expression level of both MUP 4 and 5 mRNAs in the nasal tissue was very high and exceeded that of